Prescott Group Capital Management L.L.C. bought a new stake in shares of Genesis Healthcare Inc (NYSE:GEN) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,262,721 shares of the company’s stock, valued at approximately $1,726,000.

A number of other hedge funds have also modified their holdings of the business. Schwab Charles Investment Management Inc. grew its position in shares of Genesis Healthcare by 0.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 105,432 shares of the company’s stock valued at $184,000 after purchasing an additional 646 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Genesis Healthcare by 15.8% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,188,100 shares of the company’s stock valued at $2,067,000 after purchasing an additional 161,931 shares in the last quarter. Alliancebernstein L.P. grew its position in shares of Genesis Healthcare by 10.5% during the 2nd quarter. Alliancebernstein L.P. now owns 91,826 shares of the company’s stock valued at $160,000 after purchasing an additional 8,700 shares in the last quarter. Teachers Advisors LLC grew its position in shares of Genesis Healthcare by 23.2% during the 2nd quarter. Teachers Advisors LLC now owns 62,497 shares of the company’s stock valued at $109,000 after purchasing an additional 11,753 shares in the last quarter. Finally, Northern Trust Corp grew its position in shares of Genesis Healthcare by 9.8% during the 2nd quarter. Northern Trust Corp now owns 517,110 shares of the company’s stock valued at $900,000 after purchasing an additional 46,333 shares in the last quarter. 18.55% of the stock is currently owned by institutional investors and hedge funds.

Genesis Healthcare Inc (NYSE GEN) opened at $0.96 on Friday. The company has a current ratio of 0.18, a quick ratio of 0.18 and a debt-to-equity ratio of -0.22. Genesis Healthcare Inc has a 1 year low of $0.60 and a 1 year high of $4.05.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings results on Wednesday, November 8th. The company reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.30) by ($0.06). The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.34 billion. equities analysts expect that Genesis Healthcare Inc will post -1.37 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.watchlistnews.com/prescott-group-capital-management-l-l-c-buys-new-holdings-in-genesis-healthcare-inc-gen/1859820.html.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc is a holding company that provides post-acute care. The Company operates through three segments: inpatient services, which includes the operation of skilled nursing facilities and assisted or senior living facilities; rehabilitation therapy services, which includes its integrated and third-party rehabilitation and respiratory therapy services, and all other services.

Want to see what other hedge funds are holding GEN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genesis Healthcare Inc (NYSE:GEN).

Institutional Ownership by Quarter for Genesis Healthcare (NYSE:GEN)

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.